Milestone Pharmaceuticals...

NASDAQ: MIST · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.67
-1.47%
After-hours: Aug 15, 2025, 07:57 PM EDT

Milestone Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-41.52M -59.69M -58.39M -42.85M
Depreciation & Amortization
105K 92K 89K 93K
Stock-Based Compensation
5.78M 9.53M 9.05M 7.28M
Other Working Capital
1.32M 1.24M -2.35M 1.62M
Other Non-Cash Items
3.13M 2.39M 44K 7.27M
Deferred Income Tax
n/a n/a n/a -7.27M
Change in Working Capital
3.66M 1.24M -3.26M 2.26M
Operating Cash Flow
-28.85M -46.42M -52.47M -33.22M
Capital Expenditures
-33K -112K -272K n/a
Cash Acquisitions
n/a n/a 86.12M n/a
Purchase of Investments
-113.55M -137.13M -85.85M -15M
Sales Maturities Of Investments
121.87M 142M 29M 85M
Other Investing Acitivies
-113.59M n/a -86.12M 70M
Investing Cash Flow
8.28M 4.76M -57.12M 70M
Debt Repayment
n/a 50M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
4.86M -2.21M 458K 5.05M
Financial Cash Flow
32.12M 47.79M 3.09M 5.05M
Net Cash Flow
11.55M 6.12M -106.5M 41.83M
Free Cash Flow
-28.88M -46.54M -52.74M -33.22M